Advertisement
Advertisement

Acuren backs FY25 revenue view $1.53B-$1.57B, consensus $1.56B

Backs FY25 adjusted EBITDA view $240M-$250M. The company said, “As a reminder, full-year 2025 results reflect a full year of legacy Acuren (TIC) operations and approximately five months of contribution from NV5 following the August 4, 2025 acquisition.”

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1